Efficacy and Safety of E.Coli Nissle 1917 in Patients With Mild (Stage 1-2) or Minimal Hepatic Encephalopathy
Status:
Completed
Trial end date:
2020-03-15
Target enrollment:
Participant gender:
Summary
The purpose of study to assess the short-term efficacy and safety of probiotic E.coli Nissle
1917 strain comparing to lactulose and rifaximin in patients with mild (Stage 1-2) or minimal
hepatic encephalopathy